|
[1] JIA Y,LI L,LI XG,et al. Analysis of antiviral regimen in outpatients with chronic hepatitis B[J]. Chin J Clin Pharmacol,2017,33(22):2308-2310.(in Chinese)贾莹，李璐，李晓光，等．慢性乙型病毒性肝炎患者抗病毒药物使用情况分析[J]．中国临床药理学杂志，2017,33(22):2308-2310.
|
|
[2] LIU YL,KUANG JQ,ZHANG R,et al. Analysis about clinical data of intrauterine infection of hepatitis B virus[J]. Chin J Obstetr Gynecol,2002,37(8):465-468.(in Chinese)刘颖琳，邝健全，张睿，等．胎儿感染乙型肝炎病毒的临床研究[J]．中华妇产科杂志，2002,37(8):465-468.
|
|
[3] SARIN SK,KUMAR M,SHRIVASTAVA S,et al. Influence of chronic HBV infection on pregnancy:A human model of maternofetal virus host interactions[J]. Gastroenterology,2011,141(4):1522-1525.
|
|
[4] BAI H,ZHANG L,MA L,et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism[J]. World J Gastroenterol,2007,13(26):3625-3630.
|
|
[5] LIN HH,LEE TY,CHEN DS,et al. Transplacental leakage of HBe Ag-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus[J]. J Pediatr,1987,111(6 Pt 1):877-881.
|
|
[6] YI W,PAN CQ,HAO JZ,et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers[J]. J Hepatol,2014,60(3):523-529.
|
|
[7] BAI GQ,LI SH,YUE YF,et al. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection[J]. Arch Gynecol Obstet,2011,283(2):317-321.
|
|
[8] WONG VC,LEE AK,IP HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant[J]. Br J Obstet Gynaecol,1980,87(11):958-965.
|
|
[9] PAO CC,YAO DS,LIN MY,et al. Hepatitis B virus DNA in cervicovaginal cells[J]. Arch Pathol Lab Med,1991,115(6):607-609.
|
|
[10] BEASLEY RP,STEVENS CE,SHIAO IS,et al. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B[J]. Lancet,1975,2(7938):740-741.
|
|
[11] LI XM,SHI MF,YANG YB,et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection[J]. World J Gastroenterol,2004,10(21):3215-3217.
|
|
[12] HAN GR,CAO MK,ZHAO W,et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Hepatol,2011,55(6):1215-1221.
|
|
[13] HAN L,ZHANG HW,XIE JX,et al. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus[J]. World J Gastroenterol,2011,17(38):4321-4333.
|
|
[14] CHEN HL,LEE CN,CHANG CH,et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus[J]. Hepatology,2015,62(2):375-386.
|
|
[15] ZHANG H,PAN CQ,PANG Q,et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice[J]. Hepatology,2014,60(2):468-476.
|
|
[16] HAN GR,JIANG HX,YUE X,et al. Efficacy and safety of telbivudine treatment:An open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection[J]. J Viral Hepat,2015,22(9):754-762.
|
|
[17] PIRATVISUTH T,HAN GR,POL S,et al. Comprehensive review of telbivudine in pregnant women with chronic hepatitis B[J]. World J Gastroenterol,2016,8(9):452-460.
|
|
[18] BRIDGES EG,SELDEN JR,LUO S. Nonclinical safety profile of telbivudine,a novel potent antiviral agent for treatment of hepatitis B[J]. Antimicrob Agents Chemother,2008,52(7):2521-2528.
|
|
[19] LIU M,CAI H,YI W. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy[J]. J Viral Hepat,2013,20(Suppl 1):65-70.
|
|
[20] ter BORG MJ,LEEMANS WF,de MAN RA,et al. Exacerbation of chronic hepatitis B infection after delivery[J]. J Viral Hepat,2008,15(1):37-41.
|
|
[21] APASL consensus group for the treatment of chronic hepatitis B. Asian-Pacific consensus statement on the management of chronic hepatitis B:A 2012 update[J]. J Clin Hepatol,2012,28(8):Ⅰ-ⅩⅩⅠ．(in Chinese)亚太肝病学会慢性乙型肝炎治疗共识工作组．亚太地区慢性乙型肝炎治疗共识(2012最新版)[J]．临床肝胆病杂志，2012,28(8):Ⅰ-ⅩⅩⅠ．
|
|
[22] ZHU Q,YU G,YU H,et al. A randomized control trial on interruption of HBV transmission in uterus[J]. Chin Med J(Engl),2003,116(5):685-687.
|
|
[23] YUE Y,YANG X,ZHANG S. Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin:Efficacy and mechanism[J]. Chin Med J(Engl),1999,112(1):37-39.
|
|
[24] YUAN J,LIN J,XU A,et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective:A single-centre randomized study[J]. J Viral Hepat,2006,13(9):597-604.
|
|
[25] SCHILLING R,IJAZ S,DAVIDOFF M,et al. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions[J]. J Virol,2003,77(16):8882-8892.
|
|
[26] LIANG X,BI S,YANG W,et al. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine,2009,27(47):6550-6557.
|
|
[27] LIANG X,BI S,YANG W,et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China[J]. J Infect Dis,2009,200(1):39-47.
|
|
[28] Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J]. J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ．(in Chinese)中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2010年版)[J]．临床肝胆病杂志，2011,27(1):Ⅰ-ⅩⅥ．
|
|
[29] Obstetrics Section,Society of Obstetrics and Gynecology,Chinese Medical Association. Clinical guidelines for prevention of mother-to-child transmission of hepatitis B virus(1st Edition)[J]. Chin J Obstetr Gynecol,2013,48(2):151-154.(in Chinese)中华医学会妇产科学分会产科学组．乙型肝炎病毒母婴传播预防临床指南(第1版)[J]．中华妇产科杂志，2013,48(2):151-154.
|
|
[30] CHEN HL,LIN LH,HU FC,et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV[J]. Gastroenterology,2012,142(4):773-781.
|
|
[31] ZOU H,CHEN Y,DUAN Z,et al. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers[J]. PLo S One,2011,6(10):e26748.
|
|
[32] KUBO A,SHLAGER L,MARKS AR,et al. Prevention of vertical transmission of hepatitis B:An observational study[J].Ann Intern Med,2014,160(12):828-835.
|
|
[33] LIN X,GUO Y,ZHOU A,et al. Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population:A hospital-based study and a meta-analysis[J]. Pediatr Infect Dis J,2014,33(9):897-903.
|
|
[34] WANG JS,CHEN H,ZHU QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers[J]. World J Gastroenterol,2005,11(23):3582-3585.
|
|
[35] KANG W,DING Z,SHEN L,et al. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province,China[J]. Vaccine,2014,32(27):3362-3366.
|
|
[36] FAN XH,HU YL,ZHU HL. Study on YMDD mutation during Lamivudine therapy of chronic hepatitis B[J]. J Clin Hepatol,2009,25(3):192-194.(in Chinese)樊晓红，胡玉琳，朱红玲．拉米夫定治疗慢性乙型肝炎发生YMDD变异的研究[J]．临床肝胆病杂志，2009,25(3):192-194.
|
|
[37] LIU JH,JIANG PR. Prevention of vertical transmission of hepatitis B virus from mother to child in perinatal period[J/CD].Chin J Obstet Emerg:Electronic Edition,2017,6(3):175-179.(in Chinese)刘晶华，蒋佩茹．围产期乙型肝炎病毒母婴垂直传播的防治[J/CD]．中华产科急救电子杂志，2017,6(3):175-179.
|
|
[38] CADRANEL S,ZEGHLACHE S,FERNANDEZ S,et al. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine[J]. Postgrad Med J,1987,63(Suppl 2):159-160.
|
|
[39] HALLIDAY ML,KANG LY,RANKIN JG,et al. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai,China[J]. Int J Epidemiol,1992,21(3):564-573.
|
|
[40] Centers for Disease Control and Prevention(CDC). Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data—United States[J]. MMWR Morb Mortal Wkly Rep,2011,60(13):410-413.
|
|
[41] MAST EE,MARGOLIS HS,FIORE AE,et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States:Recommendations of the Advisory Committee on Immunization Practices(ACIP)part 1:Immunization of infants,children,and adolescents[J]. MMWR Recomm Rep,2005,54(RR-16):1-31.
|
|
[42] WHO Publication. Hepatitis B vaccines:WHO position paper-recommendations[J]. Vaccine,2010,28(3):589-590.
|
|
[43] ZOU H,CHEN Y,DUAN Z,et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBs Ag-positive mothers[J]. J Viral Hepat,2012,19(2):e18-e25.
|
|
[44] WEN WH,CHANG MH,ZHAO LL,et al. Mother-to-infant transmission of hepatitis B virus infection:Significance of maternal viral load and strategies for intervention[J]. J Hepatol,2013,59(1):24-30.
|
|
[45] DANIELSSON N,FAKAKOVIKAETAU T,SZEGEDI E. Improved immunization practices reduce childhood hepatitis B infection in Tonga[J]. Vaccine,2009,27(33):4462-4467.
|
|
[46] BOOT HJ,HAHNE S,CREMER J,et al. Persistent and transient hepatitis B virus(HBV)infections in children born to HBV-infected mothers despite active and passive vaccination[J]. J Viral Hepat,2010,17(12):872-878.
|
|
[47] LUONGO M,CRITELLI R,GROTTOLA A,et al. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject:Sequence analysis and therapeutic strategy[J]. J Clin Virol,2015,62:89-91.
|
|
[48] CHONG-JIN O,WEI NING C,SHIUAN K,et al. Identification of hepatitis B surface antigen variants with alterations outside the“a”determinant in immunized Singapore infants[J]. J Infect Dis,1999,179(1):259-263.
|
|
[49] ADKINS B,LECLERC C,MARSHALL-CLARKE S. Neonatal adaptive immunity comes of age[J]. Nat Rev Immunol,2004,4(7):553-564.
|
|
[50] ELAHI S,ERTELT JM,KINDER JM,et al. Immunosuppressive CD71 erythroid cells compromise neonatal host defence against infection[J]. Nature,2013,504(7478):158-162.
|
|
[51] BEASLEY RP,HWANG LY,LEE GC,et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine[J]. Lancet,1983,2(8359):1099-1102.
|
|
[52] MILICH DR,JONES JE,HUGHES JL,et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?[J]. Proc Natl Acad Sci U S A,1990,87(17):6599-6603.
|
|
[53] PUBLICOVER J,GAGGAR A,NISHIMURA S,et al. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B[J]. J Clin Invest,2013,123(9):3728-3739.
|
|
[54] KENNEDY PTF,SANDALOVA E,JO J,et al. Preserved Tcell function in children and young adults with immune-tolerant chronic hepatitis B[J]. Gastroenterology,2012,143(3):637-645.
|
|
[55] GIBBONS D,FLEMING P,VIRASAMI A,et al. Interleukin-8(CXCL8)production is a signatory T cell effector function of human newborn infants[J]. Nat Med,2014,20(10):1206-1210.
|
|
[56] HONG M,SANDALOVA E,LOW D,et al. Trained immunity in newborn infants of HBV-infected mothers[J]. Nat Commun,2015,6:6588.
|
DownLoad: